Semalytix

📍 Bielefeld, Germany🗓 Founded 2015👥 36 employees💰 Last funded Sep 2022
Software Development🌐 semalytix.com
Website LinkedIn
Welcome to Semalytix! Semalytix, the trailblazer in AI-driven innovations, empowers pharmaceutical companies to embrace a patient-centric approach like never before. With their revolutionary Pharos platform, fuelled by state-of-the-art AI and LLM technology, Semalytix undertakes the colossal task of consuming and analysing millions of forum posts, social media discussions, and CRM system records in the blink of an eye. Pharos becomes the conduit for capturing and harnessing the pulse of real-world perceptions and experiences shared by both healthcare practitioners and patients in the here and now. Through its captivating living reports, Pharos bestows invaluable insights upon pharmaceutical giants, guiding them to laser-focus on their customers genuine needs. It unlocks the profound understanding of what truly holds the potential to enhance their well-being, transforming lives in ways previously unimagined. Founded in 2015, Semalytix has grown to a team size of 75 employees and has executed more than 40 projects with the pharmaceutical industry with a total volume of EUR 3.8M between 2015 – 2019.
6
Total investors
0
Early stage
1
Mid stage
5
Late stage
2015
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
5
Spain
1
Investor activity2018–2022 · investors recorded per year
201812021420221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Semalytix?
Semalytix has 6 investors on record on gritt.io, 1 mid-stage and 5 late-stage investors.
When did Semalytix last raise funding?
The most recent investment in Semalytix recorded on gritt.io was in September 2022.
When was Semalytix founded?
Semalytix was founded in 2015.
What industry is Semalytix in?
Semalytix operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Semalytix based?
Semalytix is headquartered in Bielefeld, Germany.